8 completed, 1 unknown. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 8, Unknown 1 |
Follow CoronaVac: new trials by email Literature Review of CoronaVac trials Research Report on CoronaVac
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E in Healthy People CoronaVac, SCTV01E - COVID-19 SARS-CoV-2 Infection | Phase 3 | Unknown | Sinocelltech Ltd. | 6000 | 2023-01-25 | 2023-01-13 |
| Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant), COVID-19 Vaccine (Vero cell), Inactivated (CZ strain) - COVID-19 | Phase 3 | Completed | Sinovac Research and Development Co., Ltd. | 1750 | 2022-06-01 | 2024-05-31 |
| Safety and Immunogenicity of COVID-19 Vaccine, Inactivated in Healthy Population Aged From 3 to 11 Years COVID-19 Vaccine,Inactivated - COVID-19 | Phase 3 | Completed | Sinovac Research and Development Co., Ltd. | 1000 | 2021-11-27 | 2023-10-16 |
| Phase 3 Booster Vaccination Against COVID-19 CoronaVac, Turkovac - COVID-19, Sars-CoV-2 Infection | Phase 3 | Completed | Health Institutes of Turkey | 4340 | 2021-10-08 | 2024-02-29 |
| Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents Inactivated COVID-19 Vaccine, Controlled vaccine - COVID-19 | Phase 3 | Completed | Sinovac Research and Development Co., Ltd. | 11349 | 2021-09-10 | 2023-10-16 |
| Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine TURCOVAC, CoronaVac - Covid19 | Phase 3 | Completed | Health Institutes of Turkey | 1290 | 2021-06-21 | 2024-02-29 |
| Efficacy, Safety, and Immunogenicity of Two Vaccination Schedules of an Inactivated Vaccine Against COVID-19 in Adults SARS-CoV-2 inactivated vaccine - Covid19, Vaccines | Phase 3 | Completed | Pontificia Universidad Catolica de Chile | 2300 | 2020-11-27 | 2023-02-02 |
| Clinical Trial For SARS-CoV-2 Vaccine (COVID-19) CoronaVac, Placebo - COVID-19 | Phase 3 | Completed | Health Institutes of Turkey | 10214 | 2020-09-14 | 2024-05-24 |
| Clinical Trial of Efficacy and Safety of Sinovac's Adsorbed COVID-19 (Inactivated) Vaccine in Healthcare Professionals Adsorbed COVID-19 (inactivated) Vaccine, Placebo - COVID-19 | Phase 3 | Completed | Butantan Institute | 12688 | 2020-07-21 | 2024-02-15 |
COVID-19 (8)
Health Institutes of Turkey (3) · Sinovac Research and Development Co., Ltd. (3) · Butantan Institute (1) · Pontificia Universidad Catolica de Chile (1) · Sinocelltech Ltd. (1)
Turkey (Türkiye) (3) · Chile (2) · China (2) · Brazil (1) · Malaysia (1) · Philippines (1) · South Africa (1)
Hongxing Pan, Master (2) · Alexis M Kalergis, PhD (1) · Katia Abarca, MD (1) · Murat Akova, Prof. (1) · Ricardo Palacios, MD, PhD (1) · Susan M Bueno, PhD (1) · Yu Sun (1) · Zeng Gang, Doctor (1)
PMID 35464483, PMID 33849629, PMID 34246358, PMID 34659237, PMID 35441164, PMID 36226829, PMID 36383021, PMID 38812507, PMID 39107270